NEWSCOPE CAPITAL : PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health Neurological and Pain Disorders
MarketScreener,
(CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, ('PharmaTher'), is a specialty life sciences company…